A Phase 2a, Multicenter, Randomized, Double-blind, Placebo Controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of VM902A in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Trial Profile

A Phase 2a, Multicenter, Randomized, Double-blind, Placebo Controlled and Active-controlled, Parallel-group Study Evaluating the Analgesic Efficacy and Safety of VM902A in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Discontinued
Phase of Trial: Phase II

Latest Information Update: 24 Nov 2017

At a glance

  • Drugs VM 902 (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Purdue Pharma
  • Most Recent Events

    • 20 Nov 2017 Status changed from suspended to discontinued.
    • 29 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 May 2018.
    • 29 Mar 2017 Planned primary completion date changed from 1 Mar 2017 to 1 May 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top